PROMPT:

HPI Comments This is a 72-year-old male with history of hypertension, dyslipidemia, type 2 diabetes mellitus, coronary artery disease with previous coronary artery bypass graft

RESPONSE:

  surgery, peripheral arterial disease, and peripheral artery disease.  Vascular Disease and Stroke (VRD)  Cardiomyopathy, pulmonary embolism, myocardial infarction and hypertension are common complications. Aspirin may also be used to treat dyslipidemia in patients with VRD, and for hypertension in patients having myocardial infarction. (See "Other Common Treatments")  Dyslipidemia (Low Cholesterol)  Cholesterol-reducing therapies are available to treat dyslipidemia and reduce cardiovascular risk. Nonenzymatic LDL-C control should be considered for patients with cardiovascular risk factors such as hypertension, peripheral arterial disease, and anemia and for those with dyslipidemia (low HDL-C and high triglycerides) on drugs of potential benefit. Cholesterol-lowering drugs including simvastatin, pravastatin, lovastatin, and fluvastatin include the following:  Diacloprid  Carcinosin  Fludarabine  Fragmin  Hydrochlorothiazide  Inderalixa  Malarone  Nilocuprofen  Penicillamine  Protezenil  Rifamycin  Rifidomedine  Rofecoxib  Severe hyperlipidemia is associated with an increased cardiovascular risk profile and may be treated using lipid-lowering medications. Cholesterol-reducing medications include the following:  Astatin  Anatostatin  Altoprevir  Bilirubin  Bortezomib  Buemocin  BuSpar  Bosentan  Calcetrapib  Centrophenoxine  Cetirizine  Chloophosophate  Corticosteroids  Dietary and Physical Activity Guidelines for Low-Income Adults  Physical Activity Guidelines  The guidelines are designed to help consumers use more effective physical activity to combat a range of chronic diseases and conditions associated with low physical activity. If the adult's lifestyle is more active than is recommended, physical activity should be maintained.  Healthy Lifestyle  The U.S. Preventive Services Task Force recommends that adults get at least 150 minutes of moderate-intensity activity (30 minutes on most